NCT06116084

Brief Summary

In Nuclear Medicine, the examinations are long (20-60 minutes) and the patients must remain immobile, sometimes fasting. The anxiety of the latter can lead to poor quality examinations and sometimes, although already injected with radioactive drugs, the patients refuse the examination. In imaging, the use of hypnosis (prior to the MRI examination or with the patient during a scintigraphic examination) is frequent due to the conformation of MRI or scintigraphic machines, particularly for claustrophobic patients (2-2.5% of cases). Medical electroradiology manipulators (MERM) have been trained to practice Ericksonian hypnosis whose effectiveness in combating anxiety is no longer in question. Scientific studies by Faymonville et al, 2006 and Rainville et al, 2002, have shown the effectiveness of this method in managing anxiety using the simplified STAI-6 scale before and after hypnosis. The dosimetric study of the MERM position would then be greatly modified in favor of a decrease in exposure targeted by the June 4, 2018 decree on personnel safety. The impact of whether or not the MERM is physically present near the patient would also be studied. If minimal, this will resolve the current contradiction between the quality of patient care delivered and the radiation protection imposed in nuclear medicine. The investigators propose here a pilot study evaluating remote-delivered Ericksonian hypnosis versus conventionally-delivered Ericksonian hypnosis, which will allow for the sizing of a subsequent multicenter randomized non-inferiority controlled trial. Indeed, there is currently no data available on the non-inferiority margin of this technique.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started May 2023

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2022

Completed
1.3 years until next milestone

Study Start

First participant enrolled

May 26, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

November 3, 2023

Status Verified

October 1, 2023

Enrollment Period

2.3 years

First QC Date

January 21, 2022

Last Update Submit

October 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in anxiety score

    Difference in anxiety score, measured using the STAI-6 score, of patients before and after scintigraphic or PET examination for each method of Ericksonian hypnosis. The scale is on 11. If the patient has a score lower than 11 he is not anxious, if the score is higher the patient is anxious.

    1 year

Secondary Outcomes (6)

  • Clinical Efficacy of heart rate

    1 year

  • Clinical Efficacy of respiratory rate

    1 year

  • Process evaluation of the intervention for the subsequent multicenter trial

    1 year

  • Process evaluation of the intervention for the subsequent multicenter trial

    1 year

  • Process evaluation of the intervention for the subsequent multicenter trial

    1 year

  • +1 more secondary outcomes

Study Arms (2)

Ericksonian hypnosis

ACTIVE COMPARATOR

An Ericksonian hypnosis session given to patients during a scintigraphic or PET examination, in a conventional manner, i.e. the hypnotherapist (MERM) is close to the patient in the examination room at the time of the session and communicates with him/her without any special device dedicated to this purpose.

Other: Ericksonian Hypnosis

Experimental hypnosis

EXPERIMENTAL

Hypnosis session with headphones and microphones

Other: Hypnosis

Interventions

An Ericksonian hypnosis session given to patients during a scintigraphic or PET examination, in a conventional manner, i.e. the hypnotherapist (MERM) is close to the patient in the examination room at the time of the session and communicates with him/her without any special device dedicated to this purpose.

Ericksonian hypnosis

A hypnosis session given to patients during a scintigraphic or PET examination, in a remote manner, i.e. the hypnotherapist (MERM) is in the control room at the time of the session and communicates with the patient via a microphone and the patient has headphones.

Experimental hypnosis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient referred for a scan or PET scan
  • Patient with a score \> 11 on the STAI-6 scale.
  • Person, speaking and understanding French
  • Having received complete information on the organization of the research and having signed the informed consent
  • Age ≥ 18 years, and ≤ 80 years.
  • Affiliated with a social security plan.

You may not qualify if:

  • People who have taken an anxiolytic treatment before going to nuclear medicine.
  • Persons referred for a neurological examination.
  • People with cognitive or auditory problems, or with a major depressive episode.
  • Persons with cardiac rhythm disorders (cardiac arrhythmias)
  • Persons who cannot perform the examination for which they need a hypnosis session
  • Women of childbearing age who do not have an effective means of contraception
  • Person referred to in articles L. 1121-5, L. 1121-7 and L1121-8 of the public health code (pregnant woman, parturient or nursing mother, adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice, adult person unable to express his consent).
  • Person deprived of liberty by a judicial or administrative decision, subject to psychiatric care under articles L. 3212-1 and L. 3213-1

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nancy Hospital

Vandœuvre-lès-Nancy, 54511, France

RECRUITING

MeSH Terms

Conditions

NeoplasmsMyocarditisAlzheimer Disease

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Martine Louis

    m.louis2@chru-nancy.fr

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anne-Sophie Hue

CONTACT

Véronique Roch

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicpal investigator

Study Record Dates

First Submitted

January 21, 2022

First Posted

November 3, 2023

Study Start

May 26, 2023

Primary Completion

September 1, 2025

Study Completion

April 1, 2026

Last Updated

November 3, 2023

Record last verified: 2023-10

Locations